AI assistant
Sending…
ETHZilla Corp — Director's Dealing 2021
Apr 9, 2021
33039_dirs_2021-04-09_855e8826-bd84-4d43-842c-1a92b743f726.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: 180 Life Sciences Corp. (ATNF)
CIK: 0001690080
Period of Report: 2021-04-07
Reporting Person: Rothbard Jonathan B. (Chief Scientific Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-04-07 | Common Stock | A | 24307 | $6.14 | Acquired | 560449 | Direct |
Footnotes
F1: Issued in consideration for accrued compensation due for services rendered as Chief Scientific Officer of the Issuer. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt from Section 16(b) pursuant to Rule 16b-3.
More from ETHZilla Corp
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 14
Regulatory Filings
2026
Apr 29
Regulatory Filings
2026
Apr 17
Regulatory Filings
2026
Apr 8
Regulatory Filings
2026
Apr 8
Regulatory Filings
2026
Apr 8
Regulatory Filings
2026
Apr 3
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 20